Valuation TAUNS Laboratories,Inc.
Stocks
197A
JP3452250008
Medical Equipment, Supplies & Distribution
|
Delayed
Japan Exchange
07:44:04 14/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 511.00 JPY | +1.79% |
|
+0.99% | +0.39% |
Company Valuation: TAUNS Laboratories,Inc.
Data adjusted to current consolidation scope
| Fiscal Period: June | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| Market Cap 1 | 41,000 | 55,086 | 53,565 | - | - |
| Change | - | 34.36% | -2.76% | - | - |
| Enterprise Value (EV) 1 | 41,114 | 60,244 | 61,559 | 62,319 | 61,344 |
| Change | - | 46.53% | 2.18% | 1.24% | -1.56% |
| P/E | 7.1x | 8.67x | 10.1x | 14.9x | 13.3x |
| PBR | 3x | 3.15x | 2.72x | 2.64x | 2.51x |
| PEG | - | 1.16x | -0.5x | -0.5x | 1.1x |
| Capitalization / Revenue | 2.22x | 2.96x | 3.63x | 2.78x | 2.56x |
| EV / Revenue | 2.23x | 3.23x | 4.17x | 3.24x | 2.94x |
| EV / EBITDA | 4.72x | 6.71x | 12.2x | 9.54x | 8.66x |
| EV / EBIT | 5.12x | 7.29x | 16x | 12.9x | 11.4x |
| EV / FCF | - | - | - | - | - |
| FCF Yield | - | - | - | - | - |
| Dividend per Share 2 | 21.75 | 28 | 35.28 | 28 | 28 |
| Rate of return | 5.3% | 5.2% | 7.03% | 5.58% | 5.58% |
| EPS 2 | 57.74 | 62.07 | 49.72 | 33.75 | 37.75 |
| Distribution rate | 37.7% | 45.1% | 71% | 83% | 74.2% |
| Net sales 1 | 18,435 | 18,628 | 14,756 | 19,252 | 20,884 |
| EBITDA 1 | 8,706 | 8,980 | 5,325 | 6,531 | 7,085 |
| EBIT 1 | 8,030 | 8,265 | 3,846 | 4,833 | 5,387 |
| Net income 1 | 5,774 | 6,315 | 5,201 | 3,593 | 4,019 |
| Net Debt 1 | 114.1 | 5,157 | 7,994 | 8,755 | 7,780 |
| Reference price 2 | 410.00 | 538.00 | 502.00 | 502.00 | 502.00 |
| Nbr of stocks (in thousands) | 100,000 | 102,391 | 106,702 | - | - |
| Announcement Date | 8/13/24 A | 8/13/25 A | 8/13/26 A | - | - |
1JPY in Million2JPY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 10.1x | 4.17x | 12.18x | 7.03% | 349M | |
| -48.83x | 16.02x | -116.95x | -.--% | 21.12B | |
| 17.24x | 1.91x | 8.08x | 1.48% | 9.62B | |
| -95.51x | 13.66x | -129.79x | -.--% | 8.94B | |
| 184.63x | 6.28x | 36.1x | -.--% | 6.88B | |
| 21.25x | 4.22x | 11.65x | - | 6.54B | |
| 20.4x | 7.05x | 15.84x | 2.82% | 5.64B | |
| 21.24x | 3.52x | 10.89x | 1.77% | 4.22B | |
| 16.45x | - | - | 3.73% | 2.65B | |
| Average | 16.33x | 7.10x | -19.00x | 2.1% | 7.33B | |
| Weighted average by Cap. | -0.88x | 9.57x | -48.78x | 0.84% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 197A Stock
- Valuation TAUNS Laboratories,Inc.
Select your edition
All financial news and data tailored to specific country editions
